Market Research Reports - Research and Markets

Welcome - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Search Results

Your Search for 'The Anti-Infectives Market Outlook to : Competitive Landscape, Pipeline Analysis and Growth Opportunities' returned 5 results - Page 1 of 1

Sort by


Sorted by Rank Top-Bottom

Global Biopharma Outlook 2011
MP Advisors, Jan 2011, Pages: 391 Market Anti-Psychotics Market and Competitive Landscape Latuda Swot Analysis Next pipeline attraction after Latuda Key Milestones Appendix 1 Monthly Sales Trend Eisai Aricept Lifecycle Management

Drug Device Combination Market to 2016 - Technological Convergence to be the New Business Model for Growth and Profitability
GBI Research, Jan 2011, Pages: 95 also reviews the competitive landscape and a detailed analysis of the pipeline products. The report also reviews details about important merger and acquisition deals that have taken place in the drug

Prescription Drugs - Global Strategic Business Report
Global Industry Analysts, Inc., July 2009, Pages: 1810 III-83 A.Market Analysis III-83 Current and Future Analysis III-83 Generics Promotion in Japan III-83 Ageing Population - A Prime Target III-83 Competitive Landscape III-84 Table 51: Leading

Hospital Antibiotics Pipeline Analysis: Big Pharma's Retreat Creates Opportunities for Biotech
Decision Resources, Inc., May 2005, Pages: 106 Pipeline Analysis: Big Pharma's Retreat Creates Opportunities for Biotech

Pharmaceutical Licensing Overview
Datamonitor, March 2010, Pages: 114 to offset the 2011 patent cliff by incorporating more advanced-stage products into its pipelines to enhance short/mid-term growth. GlaxoSmithKline was by far the most active Big Pharma player. While many

Results:

First -

Prev -

1 -

Next -

Last

For enquiries please call us on:

+353-1-415-1241 (GMT Office Hours)

1-800-526-8630 (US/Canada Toll Free)

1-917-300-0470 (EST Office Hours)